S
Shanthi Sabarimurugan
Researcher at VIT University
Publications - 31
Citations - 383
Shanthi Sabarimurugan is an academic researcher from VIT University. The author has contributed to research in topics: Meta-analysis & Systematic review. The author has an hindex of 9, co-authored 30 publications receiving 265 citations. Previous affiliations of Shanthi Sabarimurugan include Curtin University & University of Western Australia.
Papers
More filters
Journal ArticleDOI
Prognostic significance of blood inflammatory biomarkers NLR, PLR, and LMR in cancer-A protocol for systematic review and meta-analysis.
Chellan Kumarasamy,Shanthi Sabarimurugan,Royam Madhav Madurantakam,Kartik Lakhotiya,Suja Samiappan,Siddhratha Baxi,Ramesh Nachimuthu,Kodiveri Muthukaliannan Gothandam,Rama Jayaraj +8 more
TL;DR: This meta-analysis protocol examines the comparative utility of neutrophil-lymphocyte-ratio, platelet-ly mphocyte- ratio, and monocyte-lyymphocyte-Ratio as a simple, inexpensive, and effective method for cancer prognosis, in multiple cancers.
Journal ArticleDOI
Clinical Theragnostic Relationship between Drug-Resistance Specific miRNA Expressions, Chemotherapeutic Resistance, and Sensitivity in Breast Cancer: A Systematic Review and Meta-Analysis
Rama Jayaraj,Sankaranarayanan Gomathi Nayagam,Ananya S. Kar,Shubhangi Sathyakumar,Hina Mohammed,Maria Smiti,Shanthi Sabarimurugan,Chellan Kumarasamy,T Priyadharshini,Kodiveri Muthukaliannan Gothandam,N Ramesh,Ajay Gupta,Siddhartha Baxi,Suja Swamiappan,Sunil Krishnan +14 more
TL;DR: A comprehensive systematic review and meta-analysis on the role of miRNAs in influencing the chemoresistance and sensitivity of breast cancer suggests there are different mi RNAs involved in the regulation of chemores resistance through diverse drug genetic targets.
Journal ArticleDOI
Systematic Review and Meta-analysis of the Prognostic Significance of miRNAs in Melanoma Patients
Shanthi Sabarimurugan,Madhav Madurantakam Royam,Ankita Das,Shrestha Das,Gothandam K M,Rama Jayaraj +5 more
TL;DR: The findings are inconclusive but suggest that miRNA expression could predict poor survival in melanoma patients and could act as promising prognostic marker for melanoma.
Journal ArticleDOI
Prognostic Value of miRNAs in Head and Neck Cancers: A Comprehensive Systematic and Meta-Analysis
Chellan Kumarasamy,Madurantakam Royam Madhav,Shanthi Sabarimurugan,Sunil Krishnan,Siddhartha Baxi,Ajay Gupta,Kodiveri Muthukaliannan Gothandam,Rama Jayaraj +7 more
TL;DR: Results indicate that miRNAs have potential clinical value as prognostic biomarkers in HNC, with miR-21, 125b, 34c-5p and 18a, in particular, showing great potential as progostic molecular markers.
Journal ArticleDOI
Systematic review and meta-analysis of prognostic microRNA biomarkers for survival outcome in nasopharyngeal carcinoma.
TL;DR: It is noted that the combined effect estimate of HR across multiple studies indicated that increased miRNA expression in NPC potentially leads to poor overall survival, but further large-scale prospective studies on the clinical significance of the miRNAs, with sizable cohorts are necessary in order to obtain conclusive results.